Daewoo Shipbuilding & Marine Engineering Co. has successfully delivered a 61-meter-long, 1,400-ton submarine to Indonesia, among the three that the shipbuilder won in a deal worth US$1.1 billion in 2011.
During the Submarine handover ceremony, Indonesian Minister of Defense Prabowo Subianto revealed that Daewoo Shipbuilding will support Indonesia's PT PAL shipyards in developing the ability to independently build submarines and establish partnerships with technology transfer and cooperation.
Named KRI Alugoro, the submarine's design was based on Daewoo Shipbuilding's first-built submarine, the DSME 1400 or Improved Chang Bogo-class.
Pieces of the submarine were built at Daewoo Shipbuilding's Okpo shipyard in Geoje Island and assembled at PT PAL shipyard in Surabaya, Indonesia.
It is the first submarine ever built in South East Asia. Subianto noted that it was the first time a shipyard owned by a national company, PT PAL, succeeded in submarine production.
The defense chief emphasized that Indonesia is building its defense capabilities not to threaten anyone but to preserve its independence.
He added that Indonesia needs sufficient strength to maintain sovereignty and protect its territorial integrity from foreign threats.


Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Shein Targets $26B-$27B Valuation for Hong Kong IPO
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
REPAY Stock Rises After Visa Platform Connect Collaboration 



